Ponatinib as a consolidation strategy for a second attempt at TKI discontinuation in chronic myeloid leukemia: Interim results from the restop Trial - Vergara, Almudena Zaratiegui; Carreno, Gonzalo; Marin, Francisca Ferrer; Xicoy, Blanca; Casares, Maria Teresa Gomez; Sanchez-Guijo, Fermin; Nuno, M Concepcion Ruiz; Prendes, Santiago Osorio; De Paz, Raquel; Mas, Ana Isabel Rosell; Castera, Elvira Mora; Senin, Maria Alicia; et al. (Blood, 2025)